UPDATED Aug 09, 2025
Discover large cap Norwegian Pharmaceuticals & Biotech companies that are on the OSEAX. These Pharmaceuticals & Biotech Companies are organised by Market Cap.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
PHO | NOK 61.00 | -3.5% | 25.8% | NOK 1.6b | NOK 82.50 | PS3.1x | E120.4% | 0% | ||
VISTN | NOK 24.50 | 0.8% | 12.4% | NOK 1.1b | n/a | PE14.1x | n/a | 5.1% | ||
AZT | NOK 19.15 | 4.1% | -20.2% | NOK 978.0m | NOK 17.50 | PE446.2x | E77.2% | n/a | ||
TRMED | NOK 2.38 | -4.6% | 132.9% | NOK 840.1m | n/a | PB2.5x | n/a | n/a | ||
HBC | NOK 1.75 | -1.7% | -16.7% | NOK 719.4m | n/a | PS2.6x | n/a | n/a | ||
LYTIX | NOK 9.38 | 5.4% | -14.7% | NOK 640.3m | NOK 13.00 | PS1053.1x | S39.7% | n/a | ||
NYKD | NOK 1.71 | -1.8% | -85.8% | NOK 558.4m | NOK 6.75 | PS6.6x | E1.1% | 57.6% | ||
NAVA | NOK 26.00 | 10.6% | -12.8% | NOK 459.2m | NOK 36.00 | PB2.1x | E83.6% | n/a | ||
NORD | NOK 80.10 | 0% | 93.5% | NOK 411.1m | n/a | PE3.3x | n/a | 0% | ||
ZLNA | NOK 14.70 | 6.5% | n/a | NOK 300.7m | n/a | PS5673.1x | E-26.3% | n/a | ||
SOFTX | NOK 0.11 | 7.5% | 191.9% | NOK 242.0m | n/a | PS26x | n/a | n/a | ||
EXTX | NOK 2.68 | -9.5% | -60.0% | NOK 169.5m | n/a | PB1.5x | n/a | n/a | ||
ONCIN | NOK 1.39 | -6.8% | n/a | NOK 136.3m | n/a | PS16.8x | n/a | n/a | ||
ABS | NOK 3.67 | -2.7% | -66.9% | NOK 98.6m | n/a | PS2.2x | E97.1% | n/a | ||
CRNA | NOK 0.63 | 1.3% | -64.1% | NOK 66.3m | NOK 1.00 | PE1.2x | n/a | n/a | ||
PCIB | NOK 1.50 | 6.0% | -16.0% | NOK 55.8m | n/a | PS8.3x | n/a | n/a | ||
BGBIO | NOK 1.17 | 0.7% | -89.9% | NOK 45.7m | NOK 1.90 | PS53.9x | E12.9% | n/a |